ROELMI HPC, a leader in innovative and sustainable ingredients for the cosmetic and nutraceutical markets, today opens a new chapter in its growth journey by inaugurating the new legal entity ROELMI BIOTECH along with its new production plant in Gerenzano (VA).
Dedicated to precision biofermentation and located within the Insubria BioPark – the eighth science and technology park and business incubator in Italy in the biotech sector – the new facility has been established with the goal of consolidating and integrating production capacity, ensuring ever-higher quality standards, and adopting cutting-edge technologies with full respect for the environment. In this way, the company’s know-how in white biotechnologies can evolve from laboratory research to an industrial production scale.
This achievement has its roots in a journey that began in 2008, when PRINCIPIUM B.S.I. – a company merged in ROELMI HPC in 2017 – developed a fermentation method dedicated to hyaluronic acid metabolites. The following year, this resulted in the launch of the cosmetic line PrincipHYAL®, created with the innovative “Full Spectrum Hyaluronans” technology: an approach able to generate a broad spectrum of molecular weights working in synergy, mirroring what naturally happens in the skin and opening new perspectives for the beauty and personal care industries. This vision further expanded in 2010, when the same technological foundations were applied to the nutraceutical field, leading to the creation of ExceptionHYAL®, a line of dietary supplement ingredients designed to support well-being.
Driven by the ambition to constantly push beyond its own limits, ROELMI HPC inaugurated in 2022 a dedicated Research & Development laboratory in Novara – Italy, entirely focused on fermentation and the creation of cutting-edge biotechnological processes, evolving from bench-scale research to industrial production.
Today, with the establishment of ROELMI BIOTECH, this journey reaches a new milestone: a production and research hub entirely focused on fermentation and the circular economy. By transforming by-products of the Italian industry into new resources, improving production efficiency of selected key ingredients, and aiming to reduce environmental impact, the company seeks to contribute not only to people’s well-being but also to the health of the planet.
“The opening of this facility is a source of great pride for us,” says Eleonora Santus, General Manager of ROELMI BIOTECH. “It represents a strategic step that strengthens our market presence, enhances the local area, and reaffirms our commitment to sustainable and responsible production.”
More information at: https://www.roelmihpc.com/
